A carregar...
MicroRNA‐135a‐3p as a promising biomarker and nucleic acid therapeutic agent for ovarian cancer
Ovarian cancer is the most lethal gynecologic malignancy. Recently, several molecularly targeted anticancer agents have been developed for ovarian cancer; however, its prognosis remains extremely poor. The development of molecularly targeted therapy, as well as companion diagnostics, is required to...
Na minha lista:
| Publicado no: | Cancer Sci |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5448652/ https://ncbi.nlm.nih.gov/pubmed/28231414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13210 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|